What Koru does

Koru Global is a U.S.-based boutique consulting practice that helps providers selling into biotech and pharma generate qualified demand by structuring how their value is defined and brought to market. The firm does not serve biotech or pharma end-buyers developing therapies; instead it targets three vertical segments on the supply side — scientific software vendors, services firms, and instrumentation and equipment companies — and builds value architecture anchored to the six-stage Drug/Therapy Development Lifecycle from Discovery through Post-Approval/Lifecycle Management.

The core product is the Koru Method, a five-step proprietary methodology that deconstructs an offering, stress-tests it against the drug development lifecycle, maps value to specific stakeholders, architects market engagement, and enables sales execution. Koru packages this methodology into a four-tier engagement system: Tier 1 Value Surface Identification (a structured SME workshop delivered as a scored matrix and 10–15 page report within two weeks, from $9,500), Tier 2 Campaign Architecture and Strategy (three to four weeks), Tier 3 Activation Playbook (two to three weeks, typically bundled with Tier 2), and Tier 4 Execution (a quarterly retainer for ongoing campaign management, delivered via vetted production partners).

Revenue is generated entirely through professional services fees on these engagements. GTM is sales-led, entering via a 30-minute discovery call, with explicit disqualification of pre-product organizations and accounts where budget authority and execution decision-making sit with different people. The firm operates with 1–10 employees out of Middletown, USA, serves a global market through its website (koru.global), and is led by founder/CEO Ricky Marton with Principal Marianna Pristupa heading delivery.

Name

Koru

Legal name

Koru Global

Website

https://koru.global

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

Koru Global is a U.S. boutique consultancy that uses its proprietary Koru Method to help scientific software vendors, services firms, and instrumentation/equipment companies selling into biotech and pharma structure value and generate qualified demand via tiered engagements.

Ownership category

akta.pro rank

Headquarters

HQ city

Middletown

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Marketing or Sales, Operations

Revenue model

1. Consulting and Strategy Engagements: Koru generates revenue through structured consulting engagements structured in four tiers: Tier 1 (Value Surface Identification) is a half-day to full-day session with a scored value matrix delivered as a 10-15 page report for $9,500; Tier 2 (Campaign Architecture & Strategy) is scoped per offering with founding-cohort pricing available; Tier 3 (Activation Playbook) is typically bundled with Tier 2; Tier 4 (Execution) is an ongoing quarterly retainer for campaign management.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Koru helps providers selling into biotech and pharma (scientific software vendors, services firms, and instrumentation & equipment companies) generate qualified demand through a structured, four-tier consulting engagement system built on its proprietary Koru Method. The offering moves clients from surfacing and prioritizing buyer-problem entry points (Tier 1), through campaign architecture and strategy (Tier 2), to producing campaign-ready assets such as anchor content, LinkedIn distribution, email nurture, and sales enablement (Tier 3), and optional ongoing quarterly campaign execution (Tier 4).

Product overview

Koru is a focused consulting practice that helps providers selling into biotech and pharma generate qualified demand through their proprietary Koru Method. The offering consists of a four-tier engagement system: Tier 1 (Value Surface Identification) for surfacing buyer-problem entry points, Tier 2 (Campaign Architecture & Strategy) for building campaign architecture, Tier 3 (Activation Playbook) for producing campaign-ready assets, and Tier 4 (Execution) for ongoing campaign management. The core methodology centers on anchoring value in the drug/therapy development lifecycle, from Discovery through Post-Approval/Lifecycle Management. Services are delivered through structured workshops and campaign architecture engagements.

Differentiator

Problem solved

Functional benefit

Products and services

• Value Surface Identification (Tier 1) A structured session with subject matter experts to surface and prioritize buyer-problem entry points, with persona mapping and lifecycle anchoring, delivering a scored matrix and a 10–15 page report within two weeks; intended for economic buyers and champions in biotech/pharma provider organizations.
• Campaign Architecture & Strategy (Tier 2) Full strategic campaign architecture built on Tier 1 output, including positioning thesis, strategic value themes, full asset plan, customer journey map, and metrics framework, delivered over a three to four week engagement.
• Activation Playbook (Tier 3) First wave of campaign-ready assets produced within the engagement, including anchor content, derivative articles, a LinkedIn distribution sequence, email nurture sequence, sales enablement materials, and a 30-day activation calendar, typically bundled with Tier 2.
• Execution (Tier 4) Ongoing campaign management for clients wanting the work maintained, measured, and evolved, delivered via quarterly retainer with vetted production partners, including quarterly asset production, distribution management, and performance reviews.

Quantifiable outcome

• When value is not clearly defined and structured, the right buyers never recognize relevance enough to engage; sales teams spend time filtering rather than advancing conversations; expansion opportunities are never surfaced; qualified demand never fully enters the system.

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Recent moves4 records

Expansion highlights4 records

Direct peers

• Force Management: B2B sales methodology and enablement firm serving complex enterprise sales organizations with proprietary frameworks. Comparable to Koru in selling methodology-driven consulting engagements to B2B providers in technical markets.
• closerlook: Healthcare and pharma marketing agency focused on demand generation, HCP engagement, and brand strategy for life sciences clients. Directly comparable to Koru in serving biotech/pharma providers on commercial-side strategy and demand generation.
• Heinz Marketing: B2B marketing services firm that delivers outsourced CMO and demand generation services for technology and complex B2B sellers. Comparable to Koru in providing methodology-led, services-based demand generation for technical B2B providers.
• Beghou Consulting: Pharma and biotech commercial consulting firm that helps life sciences companies optimize sales, marketing, and distribution. Directly comparable to Koru in serving providers to biotech and pharma with strategy-led commercial engagements.
• SBI (Sales Benchmark Index): B2B revenue and marketing advisory firm that combines proprietary methodology, benchmarking, and consulting to help companies improve go-to-market performance. Comparable to Koru's methodology-led, advisory-driven model applied to complex B2B sales.

Emerging players

• Reforge: Education and community platform for B2B marketing, growth, and product leaders built around proprietary frameworks and cohort-based programs. Comparable to Koru in monetizing proprietary marketing frameworks, though delivered as education rather than consulting.
• Across Health: Pharma-specialist consultancy focused on digital and omnichannel marketing strategy and execution for life sciences companies. Comparable to Koru in narrow focus on pharma commercial and marketing strategy, though more digitally oriented.

Broad incumbents

• ZS Associates: Large global management consulting firm with deep pharma and life sciences practices covering sales, marketing, and commercial operations. Overlaps with Koru's space as a much larger incumbent serving biotech and pharma commercial teams.
• Intouch Group: Full-service pharma and healthcare marketing agency offering creative, media, and commercial services to life sciences clients. A broader incumbent that competes with Koru's Tier 4 execution work as part of a wider services portfolio.

Others

• Pavilion: Private membership community for B2B revenue, marketing, and sales leaders offering benchmarking, frameworks, and peer learning. Adjacent to Koru in serving the same buyer persona (B2B marketing and revenue leaders) via a community rather than consulting model.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/koru_global
• LinkedInlinkedin.com/company/koru-global-inc

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Koru